Roseanne Gerding - Concepedia

Author

Roseanne Gerding

Research Triangle Park Foundation

Also Known As

R. Gerding, Robert K. Gerding, Roseanne Gerding, Roseanne M. Gerding

Publications

197

Citations

H-Index

Concepts

All Affiliations

Research Triangle Park Foundation GlaxoSmithKline (United States)GlaxoSmithKline (Japan)

About

Roseanne Gerding is an author at Research Triangle Park Foundation specializing in drug discovery, natural sciences, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	181
2	Natural Sciences	6	6	181
3	Biochemistry	6	6	181
4	Pharmacology	6	6	181
5	Chemical Biology	3	3	119

Roseanne Gerding

Publications

181

Citations

H-Index

Page 1

	Year	Citations
Optimization of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidine IGF-1R tyrosine kinase inhibitors towards JNK selectivity Stanley D. Chamberlain, Anikó M. Redman, Joseph W. Wilson, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryNatural SciencesMedicineReceptor Tyrosine Kinase	2008	57
Discovery and optimization of imidazo[1,2-a]pyridine inhibitors of insulin-like growth factor-1 receptor (IGF-1R) Kyle A. Emmitte, Brian J. Wilson, Erich W. Baum, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryNatural SciencesMedicineRational Drug Design	2008	32
Discovery of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidines: Potent inhibitors of the IGF-1R receptor tyrosine kinase Stanley D. Chamberlain, Joseph W. Wilson, Felix Deanda, Bioorganic & Medicinal Chemistry Letters BiochemistryMedicineNatural SciencesReceptor Tyrosine KinaseRational Drug Design	2008	30
Discovery of 3,5-disubstituted-1H-pyrrolo[2,3-b]pyridines as potent inhibitors of the insulin-like growth factor-1 receptor (IGF-1R) tyrosine kinase Samarjit Patnaik, Kirk L. Stevens, Roseanne Gerding, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryMedicineTyrosine KinaseNatural Sciences	2009	26
Synthesis and stereochemical effects of pyrrolidinyl-acetylenic thieno[3,2-d]pyrimidines as EGFR and ErbB-2 inhibitors Kirk L. Stevens, Krystal J. Alligood, Jennifer G. Badiang Alberti, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryStereochemical EffectsMedicineNatural Sciences	2008	20
Optimization of a series of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidine inhibitors of IGF-1R: Elimination of an acid-mediated decomposition pathway Stanley D. Chamberlain, Anikó M. Redman, Samarjit Patnaik, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryMedicineNatural SciencesRational Drug Design	2008	16

Page 1